Terns Pharmaceuticals, Inc. (TERN) Financials

TERN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 268.5 million 13.2 million
2023-09-30 271.7 million 13.3 million
2023-06-30 289.7 million 15.5 million
2023-03-31 301.3 million 13.6 million

TERN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -19.4 million 3.3 million
2023-09-30 -20.7 million 14.1 million
2023-06-30 -13.0 million 4.2 million
2023-03-31 -14.4 million 3.9 million

TERN Net Income

No data available :(

TERN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 263.4 million - 603000
2023-09-30 266.6 million - 770000
2023-06-30 285.6 million - 876000
2023-03-31 297.5 million - 1.0 million

TERN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 72.3 million
2023-09-30 71.5 million
2023-06-30 71.4 million
2023-03-31 69.8 million

TERN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 44000 17.5 million 6.6 million 220000
2023-09-30 8000 14.8 million 18.4 million -
2023-06-30 - 14.2 million 7.0 million -
2023-03-31 - 17.1 million 7.1 million -

TERN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 220000
2023-09-30 - 222000
2023-06-30 - 217000
2023-03-31 - 222000

TERN

Price: $5.44

52 week price:
3.26
14.04

Earnings Per Share: -1.27 USD

P/E Ratio: -6.83

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 59800

Market Capitalization: 303.2 million

Links: